Eris Lifesciences Limited (BOM:540596)
India · Delayed Price · Currency is INR 1,176.20
-21.30 (-1.78%)
At close: Oct 28, 2026
Eris Lifesciences Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Assets
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 2,541 | 555.2 | 2,005 | 13,389 | 560.22 | 508.7 |
Short-Term Investments | - | - | 50 | - | 0.02 | 619.01 |
Trading Asset Securities | - | - | - | - | 300.05 | 995.46 |
Cash & Short-Term Investments | 2,541 | 555.2 | 2,055 | 13,389 | 860.29 | 2,123 |
Cash Growth | 239.97% | -72.98% | -84.65% | 1456.29% | -59.48% | 65.11% |
Accounts Receivable | 6,319 | 6,803 | 4,586 | 4,220 | 2,927 | 1,610 |
Other Receivables | - | 1,682 | 1,110 | 1,435 | 1,617 | 244.69 |
Receivables | 7,087 | 9,013 | 5,754 | 5,710 | 4,584 | 2,084 |
Inventory | 4,745 | 4,368 | 3,348 | 1,890 | 1,314 | 1,179 |
Prepaid Expenses | - | 368.9 | 200.4 | 256.2 | 172.83 | 214.39 |
Other Current Assets | 3,635 | 1,093 | 905.2 | 1,775 | 715.84 | 672.23 |
Total Current Assets | 18,009 | 15,399 | 12,262 | 23,020 | 7,647 | 6,273 |
Property, Plant & Equipment | 11,106 | 8,798 | 7,288 | 5,583 | 3,774 | 1,919 |
Long-Term Investments | 602.8 | 620.3 | 622 | 157.3 | 68.77 | 4,208 |
Goodwill | 6,918 | 9,120 | 9,120 | 8,672 | 3,318 | 934.74 |
Other Intangible Assets | 34,618 | 35,672 | 37,327 | 29,134 | 18,806 | 6,596 |
Long-Term Deferred Tax Assets | 2,984 | 2,429 | 2,890 | 3,070 | 2,739 | 2,431 |
Other Long-Term Assets | 1,564 | 1,606 | 843.7 | 758.7 | 309.96 | 330.82 |
Total Assets | 75,812 | 73,655 | 70,364 | 70,405 | 36,673 | 22,721 |
Liabilities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Accounts Payable | 4,557 | 3,297 | 3,324 | 2,189 | 1,248 | 1,178 |
Accrued Expenses | - | 2,062 | 2,065 | 972.6 | 288.05 | 209.65 |
Short-Term Debt | - | 4,539 | 3,966 | 17,488 | 701.22 | 92.7 |
Current Portion of Long-Term Debt | 19,543 | 8,999 | 2,876 | 3,319 | 1,306 | - |
Current Portion of Leases | 101.1 | 87.5 | 120.5 | 89.8 | 77.21 | 40.02 |
Current Income Taxes Payable | 138.2 | 777.6 | 436.1 | 395.9 | 39 | 69.97 |
Current Unearned Revenue | - | 281.9 | 194 | 44.5 | 37.7 | 5.65 |
Other Current Liabilities | 2,471 | 727.1 | 866.1 | 821 | 735.88 | 400.73 |
Total Current Liabilities | 26,811 | 20,771 | 13,846 | 25,321 | 4,432 | 1,996 |
Long-Term Debt | 4,275 | 9,558 | 17,375 | 6,545 | 6,444 | 450 |
Long-Term Leases | 375.9 | 401.9 | 442.1 | 370.2 | 389.74 | 353.94 |
Long-Term Unearned Revenue | - | 10.7 | 64 | 76.6 | 87.39 | 56.88 |
Pension & Post-Retirement Benefits | - | 369.2 | 219.2 | 96.1 | 38.81 | 8.92 |
Long-Term Deferred Tax Liabilities | 1,787 | 3,051 | 5,185 | 5,344 | 2,576 | 460.94 |
Other Long-Term Liabilities | 1,147 | 536.6 | 515.3 | 431.1 | 497.39 | 312.22 |
Total Liabilities | 34,396 | 34,699 | 37,647 | 38,184 | 14,467 | 3,639 |
Shareholders' Equity
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Common Stock | 138.7 | 138.5 | 136.2 | 136 | 135.99 | 135.93 |
Additional Paid-In Capital | - | 4,608 | 293.4 | 180.7 | 151.01 | 106.13 |
Retained Earnings | - | 34,070 | 27,928 | 25,409 | 21,559 | 18,737 |
Comprehensive Income & Other | 41,305 | 210.3 | 186.4 | 135.7 | 113.58 | 104.52 |
Total Common Equity | 41,443 | 39,027 | 28,544 | 25,862 | 21,960 | 19,083 |
Minority Interest | -27.6 | -70.1 | 4,174 | 6,359 | 246.89 | -1.08 |
Shareholders' Equity | 41,416 | 38,957 | 32,718 | 32,221 | 22,207 | 19,082 |
Total Liabilities & Equity | 75,812 | 73,655 | 70,364 | 70,405 | 36,673 | 22,721 |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Total Debt | 24,295 | 23,586 | 24,779 | 27,813 | 8,918 | 936.66 |
Net Cash (Debt) | -21,754 | -23,031 | -22,725 | -14,424 | -8,058 | 1,187 |
Net Cash Growth | - | - | - | - | - | 5.46% |
Net Cash Per Share | -157.65 | -168.26 | -166.73 | -105.93 | -59.18 | 8.73 |
Filing Date Shares Outstanding | 138.63 | 138.54 | 136.16 | 136.03 | 135.99 | 135.93 |
Total Common Shares Outstanding | 138.63 | 138.54 | 136.16 | 136.03 | 135.99 | 135.93 |
Working Capital | -8,803 | -5,373 | -1,584 | -2,300 | 3,215 | 4,277 |
Book Value Per Share | 298.96 | 281.69 | 209.63 | 190.12 | 161.48 | 140.39 |
Tangible Book Value | -92.7 | -5,765 | -17,903 | -11,943 | -164.57 | 11,552 |
Tangible Book Value Per Share | -0.67 | -41.61 | -131.48 | -87.80 | -1.21 | 84.99 |
Land | - | 1,274 | 1,175 | 490.8 | 229.18 | 195.33 |
Buildings | - | 2,523 | 2,464 | 1,973 | 1,240 | 326 |
Machinery | - | 4,503 | 4,221 | 3,525 | 2,268 | 1,299 |
Construction In Progress | - | 1,715 | 667.4 | 190.6 | 213.78 | 240.04 |
Leasehold Improvements | - | 110.4 | 116.3 | 109.9 | 92.81 | 84.8 |